EDIT:NASDAQ
Editas Medicine Inc
$2.57
arrow_upward
+0.78%(+0.020) 1D
Nov 6, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.55
High
$2.63
Low
$2.48
Mkt. cap
394.70M
Avg. vol.
2.28M
Volume
0.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
Open
$2.55
High
$2.63
Low
$2.48
Mkt. cap
394.70M
Avg. vol.
2.28M
Volume
0.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Benzinga
·
54 minutes ago
History Suggests Last Week's Selloff Was a Buying Opportunity - State Street SPDR S&P 500 ETF Trust (ARCA
BigGo Finance
·
4 hours ago
Goldman Sachs Panic Index Breaches Extreme 9.5 Threshold; History Shows S&P 500 Averaged 4.6% Gain Over Following Three Months
JournalArta
·
2 hours ago
Tech Stocks Now Cheaper Than S&P 500 for First Time Since 2017
The Motley Fool
·
14 hours ago
No Matter What Happens to the S&P 500 in November, These 3 Dividend Stocks Belong in Your Portfolio
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com